The percentage of residual DCIS in patients diagnosed with primary invasive breast cancer treated with neoadjuvant systemic therapy: A nationwide retrospective study
In: European journal of surgical oncology, Jg. 48 (2022), Heft 1, S. 60-66
Online
serialPeriodical
Zugriff:
Titel: |
The percentage of residual DCIS in patients diagnosed with primary invasive breast cancer treated with neoadjuvant systemic therapy: A nationwide retrospective study
|
---|---|
Autor/in / Beteiligte Person: | Ploumen, R. A.W. ; Keymeulen, K. B.M.I. ; Kooreman, L. F.S. ; van Kuijk, S. M.J. ; Siesling, S. ; Smidt, M. L. ; van Nijnatten, T. J.A. ; Centre, TechMed ; Health Technology & Services Research |
Link: | |
Zeitschrift: | European journal of surgical oncology, Jg. 48 (2022), Heft 1, S. 60-66 |
Veröffentlichung: | 2022 |
Medientyp: | serialPeriodical |
ISSN: | 0748-7983 (print) ; 1532-2157 (print) |
DOI: | 10.1016/j.ejso.2021.10.016 |
Sonstiges: |
|